Thursday, November 19, 2009
Print Current Day:
|
|
SESSION 9 SCHEDULE | |
Thursday
SESSION 9:
TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS: ENDOVASCULAR HEART VALVES, ASCENDING AORTA AND ARCH LESIONS, IN SITU FENESTRATION, IMPROVED OPEN SURGICAL APPROACHES
xxxx
Moderators:TBD
|
|
x | |
6:35 AM - 6:40 AM | Opening Remarks |
6:40 AM - 6:45 AM | Training Issues In Cardiac Surgery |
Presenters(s):Grayson H. Wheatley, MD | |
6:46 AM - 6:51 AM | Access Problems With Endovascular Aortic Valve Repair And How To Handle Them |
6:52 AM - 6:57 AM | Updated Experience With The Percutaneous Self-Expanding CORE Aortic Valve |
6:58 AM - 7:03 AM | Current State-of-the-Art With Endovascular Aortic Valve Repair |
Presenters(s):Martin B. Leon, MD | |
7:04 AM - 7:09 AM | Overview Of Percutaneous And Other Less Invasive Mitral Valve Treatments |
Presenters(s):Ted Feldman, MD | |
7:10 AM - 7:15 AM | The Future For Endovascular Repair Of Type A Aortic Dissections: Concept And Initial Clinical Experience |
7:16 AM - 7:22 AM | Panel Discussion |
7:22 AM - 7:27 AM | Where Are We With Branched Grafts For Treatment Of Aortic Arch Lesions? |
7:28 AM - 7:33 AM | Aortic External Graft Wrapping Makes Hybrid Procedures Successful And The Best Treatment For Aortic Arch Pathology: Technical Tips For Doing It Right |
7:34 AM - 7:39 AM | Open Repair Is Still The Best Option For Arch Aneurysms In Most Patients |
Presenters(s):Hazim J. Safi, MD | |
7:40 AM - 7:45 AM | Aortic Arch And TAA Repair Via A Left Thoracotomy: A New Technique |
7:46 AM - 7:51 AM | Is In Situ Fenestration The Way To Go For Revascularization Of Supra-Aortic Branches In Association With Endovascular Repair Of Arch Aneurysms? |
7:52 AM - 7:57 AM | Endovascular Total Arch Replacement Using In Situ Fenestration Methods: Techniques, Tricks And Early Clinical Experience |
Presenters(s):Bjõrn Sonesson, MD, PhD | |
7:58 AM - 8:04 AM | Panel Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Thursday
SESSION 10:
MORE ABOUT THORACIC ENDOGRAFTING AND TREATMENT OF DISSECTING ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
8:04 AM - 8:09 AM | What Is Optimal Medical Treatment For Type B Aortic Dissections: How Well Does It Work? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
8:10 AM - 8:15 AM | Debate 1: All Acute Type B Aortic Dissections Should Be Treated With An Endograft: We Don’t Need Level I Evidence |
8:16 AM - 8:21 AM | Debate 1: Nonsense, We Do Need Level I Evidence Comparing Medical Treatment With TEVAR For Uncomplicated Type B Aortic Dissection: Early Results Of Such A Trial (The ADSORB Trial) |
8:22 AM - 8:27 AM | Lessons Learned In Endograft Treatment Of More Than 550 Patients With Type B Aortic Dissections: How To Manage Retrograde Type A Dissections |
Presenters(s):Wei Guo Fu, MD | |
8:28 AM - 8:33 AM | Debate 2: For Type B Aortic Dissections Short TEVAR Coverage Of The Primary Tear Is Best |
8:34 AM - 8:39 AM | Debate 2: For Type B Aortic Dissections TEVAR Should Cover The Entire Thoracic Aorta |
8:40 AM - 8:45 AM | Oral Anticoagulation In Type B Aortic Dissections Has A Beneficial Effect On Secondary Dilatation And Malperfusion |
8:46 AM - 8:51 AM | Potential Devices For Complete Endovascular Repair Of Complex Type B Aortic Dissecting Aneurysms: The Hollow Hat Small Endograft For Leaks At Branch Reentry Sites |
Presenters(s):Zaiping Jing, MD | |
8:52 AM - 8:57 AM | Experience With Endo TAA Repair With Branched Endografts: When Can This Technology Not Be Used? |
8:58 AM - 9:03 AM | Single Center Experience With Treatment Of Malperfusion From Type B Aortic Dissections |
9:04 AM - 9:10 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
NEW DEVELOPMENTS AND TECHNIQUES IN TEVAR AND DEALING WITH ITS COMPLICATIONS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
9:10 AM - 9:15 AM | Debate 3: Left Subclavian Artery Coverage During TEVAR Is Relatively Safe: When Is It Not? |
9:16 AM - 9:21 AM | Debate 3: Left Subclavian Artery Flow Must Be Preserved During TEVAR: If Covered The Left Subclavian Must Be Revascularized |
9:22 AM - 9:27 AM | Management Of Recurrent Aneurysms After TEVAR From Endograft Failure Or Disease Progression |
Presenters(s):Geoffrey H. White, MD | |
9:28 AM - 9:33 AM | What Are Malignant Aortic Dissections And How Are They Best Treated Endovascularly: The MAD REDEEM Concept |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
9:34 AM - 9:39 AM | Direct Placement Of Large Sheaths In The Aorta Or Common Iliacs For TEVAR: Techniques And Tricks For Doing It Safely |
9:40 AM - 9:45 AM | Computational Hemodynamics And Its Importance In Acute Thoracic Aortic Disease |
9:46 AM - 9:51 AM | New Endovascular Procedures For Better Treatment Of Chronic Type B Dissections With Aneurysm Formation |
9:52 AM - 9:57 AM | TEVAR After Previous AAA Repair Is Relatively Safe: When Is Spinal Drainage Necessary? |
9:58 AM - 10:03 AM | A Blood Test For Thoracic Aortic Aneurysms |
10:04 AM - 10:09 AM | Use Of Atrium ICAST Covered Stents To Treat Aortic Coarctation And Associated Aneurysms: Are They Safer Than Bare Stents? |
10:10 AM - 10:18 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
6:40 AM - 6:45 AM | Opening Remarks |
6:45 AM - 6:50 AM | Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost? |
6:51 AM - 6:56 AM | Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof? |
6:57 AM - 7:03 AM | Debate 4: Atherectomy Devices Are A Waste Of Time And Money |
7:04 AM - 7:09 AM | Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents? |
7:10 AM - 7:15 AM | Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When? |
7:16 AM - 7:21 AM | Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions |
7:22 AM - 7:27 AM | Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions |
7:28 AM - 7:33 AM | Debate 5: It Is Not So Clear That Drug Eluting Balloons Work |
7:34 AM - 7:39 AM | Prevention And Treatment Of In-Stent Restenosis |
7:40 AM - 7:45 AM | Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions? |
7:46 AM - 7:58 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
7:59 AM - 8:04 AM | Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies? |
8:05 AM - 8:10 AM | 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions |
8:11 AM - 8:16 AM | Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things? |
8:17 AM - 8:22 AM | New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience |
8:23 AM - 8:28 AM | Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above |
8:29 AM - 8:34 AM | Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia |
8:35 AM - 8:40 AM | New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics? |
8:41 AM - 8:46 AM | Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty |
8:47 AM - 8:52 AM | Incidence Of Embolization After Lower Extremity Percutaneous Revascularization |
8:53 AM - 8:58 AM | Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade |
8:59 AM - 9:10 AM | Panel Discussion |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
9:10 AM - 9:15 AM | Devices And Simplified Strategies For Crossing Total Occlusions |
9:16 AM - 9:21 AM | Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI) |
9:22 AM - 9:27 AM | DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial |
9:28 AM - 9:33 AM | Below-Knee DES For CLI: Results With 2-Year Follow-Up |
9:34 AM - 9:39 AM | Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates |
Presenters(s):Ralf R. Kolvenbach, MD | |
9:40 AM - 9:45 AM | Debate 6: DES In The SFA Will Have A Positive Impact |
9:46 AM - 9:51 AM | Debate 6: DES In The SFA Are Not Needed |
9:52 AM - 9:57 AM | 5-Year Results With Zilver Stents Across The Knee Are Good |
9:58 AM - 10:03 AM | With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments |
10:04 AM - 10:18 AM | Panel Discussion CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions. |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
10:20 AM - 10:25 AM | Advanced Interventional Techniques In Fempop And Crural Arteries For CLI: The Role Of Plain Old Balloon PTA (POBA) |
10:26 AM - 10:31 AM | Debate 7: New Developments In Subintimal Angioplasty: It Is A Desirable Method |
10:32 AM - 10:37 AM | Debate 7: Subintimal Angioplasty For CLI Is A Technical Error Not A First Choice Procedure |
10:38 AM - 10:43 AM | Advantages, Disadvantages And Technical Tips For Subintimal Angioplasty |
10:44 AM - 10:49 AM | New Options For Restenosis In The SFA |
10:50 AM - 10:55 AM | ICAST Balloon-Expandable Stents And Covered Stents In The Lower Extremity: Results Of The ICARUS Trial |
10:56 AM - 11:01 AM | Endovascular Methods To Treat Severely Calcified SFAs Successfully |
11:02 AM - 11:07 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
11:07 AM - 11:12 AM | Debate 8: TASC II Is A Good Decision Making Tool |
11:13 AM - 11:18 AM | Debate 8: TASC II Is Too Complicated And Not Worthwhile As A Treatment Guide |
11:19 AM - 11:24 AM | Methods For Stenting Infrainguinal Lesions At Bifurcations Safely And Effectively: Something We All Need To Know |
11:25 AM - 11:30 AM | Stenting Of Lesions At Tibial Bifurcations: Indications And Techniques |
11:31 AM - 11:36 AM | Debate 9: Endovascular Techniques Can Effectively Treat Virtually All Patients With CLI: Open Surgery Is Almost Never Needed |
11:37 AM - 11:42 AM | Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: An Interventionalist’s Perspective |
11:43 AM - 11:48 AM | Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: A Vascular Surgeon’s Perspective |
11:49 AM - 11:54 AM | Debate 9: Open Surgical Bypass Is The Procedure Of Choice For CLI Revascularization |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Served in the Exhibit Hall and in Other Designated Areas |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
1:00 PM - 1:05 PM | A New Technique For In Situ Fenestration To Revascularize Aortic Branches Using Electro-Magnetic Navigation |
1:06 PM - 1:11 PM | When Can Type I Endoleaks After EVAR Be Safely Observed? |
1:12 PM - 1:17 PM | How Well Is The Petticoat Concept (Open Stent Distal to a Stent-Graft) Working For Treatment Of Type B Dissections? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
1:18 PM - 1:23 AM | Update On The STABLE Trial With A Thoracic Endograft, Comprised Of A Covered Stent Above And An Open Stent Below, For Type B Aortic Dissections |
1:24 PM - 1:29 PM | Experience With Hybrid Grafting Of The Visceral And Renal Arteries From The Ascending Aorta: Is It A Better Way? |
1:30 PM - 1:35 PM | 8-Year Experience With The VORTEC Procedure: Viabahn Technique For Revascularization Of Aortic Branch Vessels Without Clamping Or Circumferential Dissection: Is It A Better Way? |
1:36 PM - 1:41 PM | An Improved Preloaded Fenestrated Endograft For Pararenal AAAs: Advantages, Technical Description And Initial Clinical Experience |
1:42 PM - 1:47 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
1:47 PM - 1:52 PM | Tissue Glue And Coil Embolization For Difficult Type I Endoleaks: Technique And Midterm Results |
1:53 PM - 1:58 PM | Optimal Techniques For Surveillance After EVAR In 2009 And Beyond |
1:59 PM - 2:04 PM | AAA Sac Pressure Measurements Are Helpful Since Many Type II Endoleaks Should Be Treated Because They Can Cause AAA Ruptures |
2:05 PM - 2:10 PM | Technique For Continuous Supraceliac Balloon Aortic Control With Ruptured AAAs And Hemodynamic Collapse (Video Presentation) |
2:11 PM - 2:16 PM | A New System For Electronic Image Marking To Simplify Interventional Procedures |
2:17 PM - 2:22 PM | Is EVAR The Treatment Of Choice For Inflammatory AAAs? |
2:23 PM - 2:28 PM | Panel Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2009 (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
2:28 PM - 2:33 PM | Debate 10: CAS Is Dead Based On Population Based Studies And Level I Evidence |
2:34 PM - 2:39 PM | Debate 10: CAS Is Not Dead: It Will Have A Role In Symptomatic Patients When Used With New And Better Technology (Better Stents/Flow Reversal) And Better Patient Selection |
2:40 PM - 2:45 PM | Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This? |
2:46 PM - 2:51 PM | New Key Information From The SPACE Trial: Cerebral Protection vs. No Cerebral Protection: Timing Of Strokes With CAS; Incidence Of Restenosis After CAS And CEA; Open vs. Closed Stents – Which Is Best? |
2:52 PM - 2:58 PM | Results Of The ICSS Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic Patients |
2:59 PM - 3:04 PM | 1-Year Results Of The CREST Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic And Asymptomatic Patients |
3:05 PM - 3:10 PM | Where Do We Go From Here With Randomized Trials Of CAS vs. CEA: Do We Need More Trials In Asymptomatic Patients With A Best Medical Treatment Arm; More Trials With Better Patient Selection; Or More Trials With Better Technology For CAS (Flow Reversal and Better Stent Systems)? |
3:11 PM - 3:16 PM | CAS With Proximal Protection (Flow Cessation/Reversal) And Hybrid (Cristallo) Stents: Will This Be A Better And Universally Safe Approach? |
3:17 PM - 3:22 PM | Debate 11: Indirect Markers Of Cerebral Embolization (TCD and Diffusion-Weighted MRI) Are Of Great Value In Differentiating Strategies For Embolic Protection In CAS |
3:23 PM - 3:28 PM | Debate 11: Indirect Markers Of Cerebral Embolization (TCD and DW-MRI) Are Of Little Value In Differentiating Strategies For Embolic Protection In CAS Because Most Strokes With CAS Occur Before Or After Embolic Protection Devices Are Functioning |
3:29 PM - 3:34 PM | Imaging Suite Of The Future Will Combine Many Modalities: What Can Be Combined With Fluoroscopy To Facilitate Endovascular Procedures? |
3:35 PM - 3:40 PM | Panel Discussion |
Moderator(s): TBD / TBD / TBD | |
3:40 PM - 3:45 PM | Debate 12: Medical Treatment Is Best For Most Asymptomatic Patients With Carotid Stenosis |
3:46 PM - 3:51 PM | Debate 12: CEA Or CAS, Not Medical Treatment, Is Best For Most Asymptomatic Patients With >60% Carotid Stenosis |
3:52 PM - 3:57 PM | Interventional Treatment (CAS or CEA) Should Await New Diagnostic Methods: What Is On The Horizon? |
3:58 PM - 4:03 PM | Best Medical Treatment Is Currently The Optimal Management For >60% Carotid Stenosis In Asymptomatic Patients: What Is Needed To Maximize The Benefit Of CAS In Such Patients? |
4:04 PM - 4:09 PM | Value Of Intense Lipid Lowering Treatment In Patients With Asymptomatic Carotid Stenosis |
4:10 PM - 4:15 PM | How To Identify Vulnerable Carotid Plaques In Asymptomatic Patients Noninvasively With Molecular Imaging |
4:16 PM - 4:21 PM | How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Invasively Without Treating All Asymptomatic Patients: Present Status And Future Possibilities |
4:22 PM - 4:27 PM | Effect Of Exercise And Statins On Carotid Plaques: Implications For Invasive Treatment Of Asymptomatic Patients |
4:28 PM - 4:33 PM | Status Of The TACIT Trial: Will We Ever Know The Truth About How Asymptomatic Patients With Carotid Stenosis Should Be Treated?: Will The Stimulus Package Save The Day For TACIT? |
4:34 PM - 4:39 PM | Panel Discussion |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
UPDATE ON STENT GRAFTS IN THE SFA AND POPLITEAL ARTERIES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
4:39 PM - 4:44 PM | 12-Year Experience With VIABAHN Stent-Grafts For Treatment Of Long SFA Occlusions: Technical Tips And 5 And 10-Year Patency Data |
4:45 PM - 4:50 PM | Single Center And Multicenter Results (VIBRANT Trial) Of VIABAHN Stent-Grafts vs. Uncovered Nitinol Stents For SFA Occlusive Disease |
4:51 PM - 4:56 PM | Edge Stenosis After SFA Stent-Grafting For Occlusive Disease: What Do We Know And What Can Be Done To Prevent Or Treat It: Will Heparin Bonding Improve Results? |
4:57 PM - 5:02 PM | Coverage Of Collaterals With SFA Stent-Grafts: Is It Or Is It Not A Problem? |
5:03 PM - 5:08 PM | Are Reentry Devices Worth The Effort In Complex SFA Occlusions? |
5:09 PM - 5:14 PM | 2-3-Year Results With Tissue Covered Stents For SFA Occlusive Disease: Technical Improvements In The System |
5:15 PM - 5:20 PM | Long-Term Follow-up Of VIABAHN Stent-Grafts To Treat Popliteal Aneurysms: Tips, Tricks, Precautions And When Not To Use |
5:21 PM - 5:26 PM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
5:26 PM - 5:31 PM | 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why? |
5:32 PM - 5:37 PM | Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs? |
Presenters(s):Martin B. Leon, MD | |
5:38 PM - 5:43 PM | Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them? |
5:44 PM - 5:49 PM | Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease? |
5:50 PM - 5:55 PM | Will Biodegradable Stents Replace Drug Eluting Stents? |
5:56 PM - 6:01 PM | Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When? |
6:02 PM - 6:07 PM | Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It |
6:08 PM - 6:13 PM | Panel Discussion |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Thursday
SESSION 20:
PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
6:13 PM - 6:18 PM | Superficial Femoral Artery Access For Endovascular Procedures When The Common Femoral Cannot Be Used Due To Scarring, Disease Or Infection |
6:19 PM - 6:24 PM | Neurological Complications Of TEVAR: How To Prevent And Treat Them |
6:25 PM - 6:30 PM | Advantages Of And Indications For Use Of Bivalirudin Rather Than Heparin For Endovascular Procedures |
6:31 PM - 6:36 PM | Technical Tips On Managing Abdominal Compartment Syndrome And Open Abdomen Treatment After EVAR For Ruptured AAA |
6:37 PM - 6:42 PM | Techniques For Simplified Endovascular Management Of Iatragenic Subclavian Artery Injury |
6:43 PM - 6:48 PM | EMPIRE Trial Of The Gore Parodi Flow Reversal Embolic Protection Device In CAS: Its Particular Value In Symptomatic Patients And Octogenarians |
6:49 PM - 6:54 PM | Technique For Placement Of Large Palmaz Stent For Proximal Neck Problem During EVAR: What Balloon, Sheath And Precautions Are Needed? |
6:55 PM - 7:00 PM | Use Of Covered Palmaz Stent As A Neck Extender In EVAR |
Presenters(s):Ralf R. Kolvenbach, MD | |
7:01 PM - 7:06 PM | What The Vascular Surgeon Or Interventionalist Needs To Know About Discontinuing Plavix In A Patient With A Drug Eluting Coronary Stent Needing Another Procedure |
7:07 PM - 7:15 PM | Panel Discussion |
END OF SESSION 20 |